Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian Hormone Withdrawal and Suicide Risk
NCT03720847Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol topical and progesterone in suicidal ideation (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Self-Injurious Thoughts and Behaviors Interview Suicidal Ideation Score and Self-Injurious Thoughts and Behaviors Interview Suicidal Planning Score. Started Dec 2016; status: completed.
02
Drugs
estradiol topicalprogesterone
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT03720847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720847.